Job Descriptions:
Exposure of analysis for Finished Products, Stability Samples & Raw Material
Having sound knowledge of Operation, Troubleshooting of QC Instruments & Investigation of OOS/OOT/Deviation. (eg HPLC, GC, UV, GCMS, LCMS, FTIR, Polarimeter, UV-Spectrophotometer, KF. Apparatus).
Having Knowledge of Analytical Method Validation, Verification & Method Transfer. Having skill for Data Interpretation, Troubleshooting.
Exposure of QC compliance and GLP activities.
Analyses of stability samples, in-process samples, finished goods, and raw materials (Wet & Instrumental analysis).
HPLC calibration according to a set protocol and timetable.
Printing and creating the analysis record.
Management of log books for a range of activities.
Preparation/Revision of the analysis methodology.
Reporting analytical aberrations in accordance with LIR protocol and CAPA implementation.
Overcoming daily obstacles to ensure efficient analytical work (instrument troubleshooting).
Familiarity with ICH/USFDA, cGMP, and GLP requirements.
Practical understanding of the creation and verification of methods.
Instrument handling, including spectrophotometer, GC, HPLC, and GCHS.
Preparing and reviewing reports and protocols for stability studies, Hold Time study reports and protocols, Qualification reports and protocols in accordance with the established protocol.
Hold time study samples in order to measure stability.
To draft a report on stability summary.
To confirm that the laboratory observations are compliant.
To report events, deviations from the norm, out of specifications, and/or incidents that occurred in the lab.
Validations of methods according to relevant guidelines.
Calibration of every piece of equipment and instrument used in the lab for the tests.
Establishing specifications for all of the intermediates, solvents, final goods, reagents, and raw materials and packing materials used in analysis.
Pharma knowledge of Solid orals & Quality process. USFDA, MHRA, ANVISA & Other regulatory exposure is preferred including ICH guidelines.
Contact Person's:
Shikha Sharma & Sandeep Kapil
9805508451 (Only for Message)
Email ID: shikhasharma@torrentpharma.com / sandeepkapil@torrentpharma.com
Note:Please attend interview with latest resume, one passport size photograph & latest salary slip.
One of the top pharmaceutical firms in the nation is Torrent Pharma, the flagship business of the Torrent Group. The Company is considered one of the leaders in the therapeutic segments of women's healthcare (WHC), cardiovascular (CV), central nervous system (CNS), and gastrointestinal (GI) healthcare. The Company was a pioneer in introducing the concept of niche marketing in India. Additionally, the company is well-represented in the oncology, gynecology, diabetology, pain management, and anti-infective categories.
Torrent Pharma's competitive edge is derived from its top-notch manufacturing facilities, cutting-edge research and development capabilities, vast domestic network, and global presence spanning over 40 countries.
Torrent Pharma's position in the Indian Pharma market was strengthened by the acquisition of Elder Pharma's Indian branded business in 2013, Zyg Pharma's dermatological business in 2015, Glochem Industries' API plant in 2016, women's healthcare brands from Novartis, Unichem's Indian branded business along with its Sikkim Plant in 2017, and Curatio in 2022.
In order to break into the German market, Torrent Pharma began making foreign acquisitions in 2005 when it acquired 90-year-old Heumann from Pfizer. Later in 2015, ANDA of minocycline was acquired by Ranbaxy for the US market.
Additionally, in January 2018, Torrent purchased Levittown, Pennsylvania-based Bio-Pharm, Inc. (BPI), an OTC and generic drug company.
Torrent Pharma is dedicated to providing "lifecare, not just healthcare."